Dilimulati Yalikun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Dilimulati Yalikun has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Hanlin Fu
Department of Obstetrics and Gynecology , The First Affiliated Hospital of Zhengzhou University , Zhengzhou City 450052 , Henan Province , China , zzu.edu.cn
1 shared publication - Lulu Si
Department of Obstetrics and Gynecology , The First Affiliated Hospital of Zhengzhou University , Zhengzhou City 450052 , Henan Province , China , zzu.edu.cn
1 shared publication - Ruixia Guo
Department of Obstetrics and Gynecology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Immunology Research
- Vol. 2026 (1) , 3833044
Natural Killer Cells in Uterine Adenomyosis: Immunological Mechanisms and Therapeutic Perspectives
Uterine adenomyosis (AM), a common gynecological disorder, is characterized by the invasion of endometrial glands and stroma into the myometrium, resulting in chronic pelvic inflammation and severe pain. This condition not only adversely affects patients’ quality of life but also correlates with diminished fertility. Recent findings underscore the critical role of natural killer (NK) cells in the pathophysiology of AM. As a vital component of innate immunity, NK cells are responsible for identifying and eliminating abnormal cells, and functional alterations of NK cells may contribute to the progression of this disease. Although existing research has suggested preliminary associations between NK‐cell dysfunction and AM, the exact mechanistic pathways and their clinical implications are still not fully elucidated. This review comprehensively explores the involvement of NK cells in AM, emphasizing their functional adaptability within the immune microenvironment, interactions with cytokine networks, and potential for therapeutic targeting. Furthermore, we critically assess the translational hurdles and propose a strategic framework for implementing NK cell‐based immunomodulatory approaches in clinical practice.
- 1 January 2026
- Published by Wiley in Journal of Immunology Research
- Vol. 2026 (1) , 3833044
Open AccessNatural Killer Cells in Uterine Adenomyosis: Immunological Mechanisms and Therapeutic Perspectives
Uterine adenomyosis (AM), a common gynecological disorder, is characterized by the invasion of endometrial glands and stroma into the myometrium, resulting in chronic pelvic inflammation and severe pain. This condition not only adversely affects patients’ quality of life but also correlates with diminished fertility. Recent findings underscore the critical role of natural killer (NK) cells in the pathophysiology of AM. As a vital component of innate immunity, NK cells are responsible for identifying and eliminating abnormal cells, and functional alterations of NK cells may contribute to the progression of this disease. Although existing research has suggested preliminary associations between NK‐cell dysfunction and AM, the exact mechanistic pathways and their clinical implications are still not fully elucidated. This review comprehensively explores the involvement of NK cells in AM, emphasizing their functional adaptability within the immune microenvironment, interactions with cytokine networks, and potential for therapeutic targeting. Furthermore, we critically assess the translational hurdles and propose a strategic framework for implementing NK cell‐based immunomodulatory approaches in clinical practice.